English Adalimumab Tender Marks Progress, But Is Not Perfect
An English adalimumab tender in effect from 1 December last year aided industry sustainability by awarding deals to multiple biosimilar suppliers. But there is still room for improvement, the BBA’s Warwick Smith believes.
